Women-Focused Health Startup Maven Clinic raises $125 million at $1.7 billion Valuation

Maven Clinic, a women-focused healthcare firm, announced that it was valued at $1.7 billion after raising $125 million in its latest funding round which was led by private markets investment firm 'StepStone Group'. The firm stated that their existing General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group and Lux Capital also participated in the round.

Moreover, startups addressing women’s health challenges are steadily attracting interest from venture capital investors, driven by a growing recognition of the need for targeted healthcare solutions.

The World Economic Forum and the McKinsey Health Institute revealed the report in January, finding that women spend 25% more of their lives in debilitating health as compared to men.

Founder and CEO of Maven, Kate Ryder stated, “Early on, people didn’t understand the sector's size and how powerful it is. It was one of the great missed opportunities over the last few decades in healthcare innovation. Women and family health is not just a huge area of health care that’s been undersupported and under-funded, it is the central part of health care."

Maven Founded in 2014, partners with employers and health plans to provide clinical support through its platform on preconception, family building, pregnancy, parenting, and menopause.

Based in New York, the firm caters to over 2,000 customers in 175 countries. The company said Maven's total funding raised to more than $425 million in the latest financing round. Prior Maven raised $90 million in a Series E funding round in 2022 led by General Catalyst. The company will use the proceeds to further invest in Maven Managed Benefit, its fertility benefits administration platform. It will also bolster its offerings across both fully insured and Medicaid populations.